Kidney.com redefines condition-specific healthcare AI, says M42 Group CEO
Pulse is tracking a regulatory development. Pulse is monitoring the item for material follow-up, additional figures or stronger confirmation. The initial evidence comes from a specialist source that remains under Pulse review.
